WandaLSalzerMD

Pediatric Hematology & Oncology • New Orleans, LA

Physician

Join to view full profile

Are you Dr. Salzer?

Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.

Connect with colleagues in the same hospital or clinic
You already have 46 invites waiting!
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

Claim this profile

Not you? Find your profile

Office
1514 Jefferson Hwy
New Orleans, LA 70121
Phone+1 504-842-4000
Is this information wrong?

Summary

Dr. Wanda Salzer, MD is a pediatric hematologist/oncologist in New Orleans, Louisiana. She is currently licensed to practice medicine in Louisiana and Mississippi.

Education & Training

National Capital ConsortiumFellowship, Pediatric Hematology/Oncology, 1996 - 1999
Keesler Medical CenterResidency, Pediatrics, 1993 - 1996
Tulane University School of MedicineClass of 1993

Certifications & Licensure

LA State Medical License 1994 - 2024
MS State Medical License 2001 - 2012
American Board of Pediatrics Pediatrics
American Board of Pediatrics Pediatric Hematology-Oncology

Publications & Presentations

PubMed

19 citations
Outcomes in adolescent and young adult patients (16 to 30 years) compared to younger patients treated for high-risk B-lymphoblastic leukemia: report from Children's On...
Michael J. Burke, Meenakshi Devidas, Zhiguo Chen, Wanda L. Salzer, Elizabeth A. Raetz, Karen R. Rabin, Nyla A. Heerema, Andrew J. Carroll, Julie M. Gastier-Foster, Mic...> ;Leukemia. 2021 Nov 1
2 citations
Correction to: FLT3 inhibitor lestaurtinib plus chemotherapy for newly diagnosed KMT2A-rearranged infant acute lymphoblastic leukemia: Children’s Oncology Group trial ...
Patrick A. Brown, John A. Kairalla, Joanne M. Hilden, Zo Ann E. Dreyer, Andrew J. Carroll, Nyla A. Heerema, Cindy Wang, Meenakshi Devidas, Lia Gore, Wanda L. Salzer, N...> ;Leukemia. 2021 May 1
35 citations
FLT3 inhibitor lestaurtinib plus chemotherapy for newly diagnosed KMT2A-rearranged infant acute lymphoblastic leukemia: Children's Oncology Group trial AALL0631.
Patrick A Brown, John A Kairalla, Joanne M Hilden, ZoAnn E Dreyer, Andrew J Carroll, Nyla A Heerema, Cindy Wang, Meenakshi Devidas, Lia Gore, Wanda L Salzer, Naomi J W...> ;Leukemia. 2021 May 1
8 citations
Prognostic impact of minimal residual disease at the end of consolidation in NCI standard-risk B-lymphoblastic leukemia: A report from the Children's Oncology Group.
Rachel E. Rau, Yunfeng Dai, Meenakshi Devidas, Karen R. Rabin, Patrick A. Zweidler-McKay, Anne L. Angiolillo, Reuven J. Schore, Michael J. Burke, Wanda L. Salzer, Nyla...> ;Pediatric Blood & Cancer. 2021 Feb 9
34 citations
Impact of Intrathecal Triple Therapy Versus Intrathecal Methotrexate on Disease-Free Survival for High-Risk B-Lymphoblastic Leukemia: Children’s Oncology Group Study A...
Wanda L. Salzer, Michael J. Burke, Meenakshi Devidas, Yunfeng Dai, Kristina K. Hardy, John A. Kairalla, Lia Gore, Joanne M. Hilden, Eric Larsen, Karen R. Rabin, Patric...> ;Journal of Clinical Oncology. 2020 Jun 4
90 citations
Impact of Asparaginase Discontinuation on Outcome in Childhood Acute Lymphoblastic Leukemia: A Report From the Children’s Oncology Group
Sumit Gupta, Cindy Wang, Elizabeth A. Raetz, Reuven J. Schore, Wanda L. Salzer, Eric Larsen, Kelly W. Maloney, Len A. Mattano, William L. Carroll, Naomi J. Winick, Ste...> ;Journal of Clinical Oncology. 2020 Apr 10
23 citations
Replacing cyclophosphamide/cytarabine/mercaptopurine with cyclophosphamide/etoposide during consolidation/delayed intensification does not improve outcome for pediatri...
Michael J. Burke, Wanda L. Salzer, Meenakshi Devidas, Yunfeng Dai, Lia Gore, Joanne M. Hilden, Eric Larsen, Karen R. Rabin, Patrick A. Zweidler-McKay, Michael J. Borow...> ;Haematologica. 2019 May 1
30 citations
Severe pegaspargase hypersensitivity reaction rates (grade ≥3) with intravenous infusion vs. intramuscular injection: analysis of 54,280 doses administered to 16,534 p...
Michael J. Burke, Meenakshi Devidas, Kelly W. Maloney, Anne L. Angiolillo, Reuven J. Schore, Kimberly P. Dunsmore, Eric Larsen, Len A. Mattano, Wanda L. Salzer, Stuart...> ;Leukemia & Lymphoma. 2018 Jul 3
39 citations
Toxicity associated with intensive postinduction therapy incorporating clofarabine in the very high-risk stratum of patients with newly diagnosed high-risk B-lymphobla...
Wanda L. Salzer, Michael J. Burke, Meenakshi Devidas, Si Chen, Lia Gore, Eric Larsen, Michael J. Borowitz, Brent L. Wood, Nyla A. Heerema, Andrew J. Carroll, Joanne M....> ;Cancer. 2018 Mar 15
58 citations
Asparaginase activity levels and monitoring in patients with acute lymphoblastic leukemia.
Wanda L. Salzer, Bruce Bostrom, Yoav H. Messinger, Anthony J. Perissinotti, Bernard L. Marini> ;Leukemia & Lymphoma. 2018 Jan 29
197 citations
Targetable kinase gene fusions in high-risk B-ALL: a study from the Children's Oncology Group.
Shalini C. Reshmi, Richard C. Harvey, Kathryn G. Roberts, Eileen Stonerock, Amy Smith, Heather Jenkins, I-Ming Chen, Marc Valentine, Yu Liu, Yongjin Li, Ying Shao, Joh...> ;Blood. 2017 Jun 22
178 citations
Genomic analyses identify recurrent MEF2D fusions in acute lymphoblastic leukaemia
Zhaohui Gu, Michelle L. Churchman, Kathryn G. Roberts, Yanhong Li, Yu Liu, Richard C. Harvey, Kelly McCastlain, Shalini C. Reshmi, Debbie Payne-Turner, Ilaria Iacobucc...> ;Nature Communications. 2016 Nov 8
241 citations
Dexamethasone and High-Dose Methotrexate Improve Outcome for Children and Young Adults With High-Risk B-Acute Lymphoblastic Leukemia: A Report From Children’s Oncology...
Eric C. Larsen, Meenakshi Devidas, Si Chen, Wanda L. Salzer, Elizabeth A. Raetz, Mignon L. Loh, Leonard A. Mattano, Catherine H. Cole, Alisa L. Eicher, Maureen Haugan,...> ;Journal of Clinical Oncology. 2016 Sep 27
7 citations
A Pilot Study of Intensified PEG-Asparaginase in High-risk Acute Lymphoblastic Leukemia: Children's Oncology Group Study AALL08P1.
Vilmarie Rodriguez, John A. Kairalla, Wanda L. Salzer, Elizabeth A. Raetz, Mignon Loh, Andrew J. Carroll, Nyla A. Heerema, Brent L. Wood, Michael J. Borowitz, Michael ...> ;Journal of Pediatric Hematology/oncology. 2016 Jul 26
247 citations
Prognostic significance of minimal residual disease in high risk B-ALL: a report from Children’s Oncology Group study AALL0232
Michael J. Borowitz, Brent L. Wood, Meenakshi Devidas, Mignon L. Loh, Elizabeth A. Raetz, Wanda L. Salzer, James B. Nachman, Andrew J. Carroll, Nyla A. Heerema, Julie ...> ;Blood. 2015 Aug 20
27 citations
Decreased induction morbidity and mortality following modification to induction therapy in infants with acute lymphoblastic leukemia enrolled on AALL0631: a report fro...
Wanda L. Salzer, Tamekia L. Jones, Meenakshi Devidas, ZoAnn E. Dreyer, Lia Gore, Naomi J. Winick, Lillian Sung, Elizabeth A. Raetz, Mignon L. Loh, Cindy Y. Wang, Paola...> ;Pediatric Blood & Cancer. 2015 Mar 1
58 citations
Intensified chemotherapy without SCT in infant ALL: Results from COG P9407 (Cohort 3)
ZoAnn E. Dreyer, Joanne M. Hilden, Tamekia L. Jones, Meenakshi Devidas, Naomi J. Winick, Cheryl L. Willman, Richard C. Harvey, I-Ming Chen, Fred G. Behm, Jeanette Pull...> ;Pediatric Blood & Cancer. 2015 Mar 1
36 citations
Development of asparaginase Erwinia chrysanthemi for the treatment of acute lymphoblastic leukemia
Wanda L. Salzer, Barbara L. Asselin, Paul V. Plourde, Tim Corn, Stephen P. Hunger> ;Annals of the New York Academy of Sciences. 2014 Nov 1
72 citations
Phase 2 randomized, flexible crossover, double-blinded, placebo-controlled trial of the farnesyltransferase inhibitor tipifarnib in children and young adults with neur...
Brigitte C. Widemann, Eva Dombi, Andrea Gillespie, Pamela L. Wolters, Jean B. Belasco, Stewart Goldman, Bruce R. Korf, Jeffrey Solomon, Staci Martin, Wanda L. Salzer, ...> ;Neuro-Oncology. 2014 May 1
56 citations
Erwinia asparaginase achieves therapeutic activity after pegaspargase allergy: a report from the Children's Oncology Group
Wanda L. Salzer, Barbara L. Asselin, Jeffrey G. Supko, Meenakshi Devidas, Nicole A. Kaiser, Paul V. Plourde, Naomi J. Winick, Gregory H. Reaman, Elizabeth A. Raetz, Wi...> ;Blood. 2013 Jul 25
38 citations
18-fluorodeoxyglucose-positron emission tomography (FDG-PET) evaluation of nodular lesions in patients with Neurofibromatosis type 1 and plexiform neurofibromas (PN) o...
Holly J. Meany, Eva Dombi, James C. Reynolds, Millie Whatley, Ambereen Kurwa, Maria Tsokos, Wanda L. Salzer, Andrea Gillespie, Andrea Baldwin, Joanne Derdak, Brigitte ...> ;Pediatric Blood & Cancer. 2013 Jan 1
21 citations
Modifications to induction therapy decrease risk of early death in infants with acute lymphoblastic leukemia treated on Children's Oncology Group P9407
Wanda L. Salzer, Tamekia L. Jones, Meenakshi Devidas, Joanne M. Hilden, Naomi J. Winick, Stephen P. Hunger, William L. Carroll, Bruce M. Camitta, ZoAnn E. Dreyer> ;Pediatric Blood & Cancer. 2012 Nov 1
19 citations
Erwinia asparaginase in pediatric acute lymphoblastic leukemia
Wanda L. Salzer, Nita L. Seibel, Malcolm A. Smith> ;Expert Opinion on Biological Therapy. 2012 Sep 11
14 citations
Plasma Methotrexate, Red Blood Cell Methotrexate and Red Blood Cell Folate Values and Outcome in Children with Precursor B Acute Lymphoblastic Leukemia: A Report from ...
Wanda L. Salzer, Naomi J. Winick, Pierre Wacker, Xiaomin Lu, Meenakshi Devidas, Jonathan J. Shuster, Donald H. Mahoney, Stephen J. Lauer, Bruce M. Camitta> ;Journal of Pediatric Hematology/oncology. 2012 Jan 1
73 citations
Tolerability and efficacy of L-asparaginase therapy in pediatric patients with acute lymphoblastic leukemia.
Elizabeth A. Raetz, Wanda L. Salzer> ;Journal of Pediatric Hematology/oncology. 2010 Oct 1
Join now to see all